UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

International Journal of Obesity, 2012-03, Vol.36 (3), p.422-430

2012

Volltextzugriff (PDF)

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

Clinical genetics, 2017-01, Vol.91 (1), p.131-136

2017

Volltextzugriff (PDF)

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2608-2613

2010

Volltextzugriff (PDF)

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2671-2679

2010

Volltextzugriff (PDF)

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Diabetologia, 2001-11, Vol.44 (11), p.2025-2031

2001

Volltextzugriff (PDF)

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Circulation (New York, N.Y.), 1997-08, Vol.96 (3), p.761-768

1997

Volltextzugriff (PDF)

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort

Arteriosclerosis, thrombosis, and vascular biology, 1998-01, Vol.18 (1), p.84-91

1998

Volltextzugriff (PDF)

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

International Journal of Obesity, 1998-04, Vol.22 (4), p.312-317

1998

Volltextzugriff (PDF)

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

Diabetes (New York, N.Y.), 1999-04, Vol.48 (4), p.890-895

1999

Volltextzugriff (PDF)

Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss

International Journal of Obesity, 2015-03, Vol.39 (3), p.480-487

2015

Volltextzugriff (PDF)

Expression of adrenomedullin in adipose tissue of lean and obese women

European journal of endocrinology, 2006-07, Vol.155 (1), p.177-185

2006

Volltextzugriff (PDF)

The role of actigraphy in the study of sleep and circadian rhythms

Sleep (New York, N.Y.), 2003-05, Vol.26 (3), p.342-392

2003

Volltextzugriff (PDF)

Headache during pregnancy

Cephalalgia, 1997-11, Vol.17 (7), p.765-769

1997

Volltextzugriff (PDF)

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

Arteriosclerosis, thrombosis, and vascular biology, 2003-07, Vol.23 (7), p.1262-1268

2003

Volltextzugriff (PDF)

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.791-797

2003

Volltextzugriff (PDF)

Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.800-805

2001

Volltextzugriff (PDF)

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.942-949

2010

Volltextzugriff (PDF)

Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

Blood, 2001-04, Vol.97 (7), p.2053-2058

2001

Volltextzugriff (PDF)

Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation

Journal of thrombosis and haemostasis, 2008-11, Vol.6 (11), p.1975-1977

2008

Volltextzugriff (PDF)

Endothelial cell dysfunction in HIV infection

Journal of acquired immune deficiency syndromes (1988), 1992, Vol.5 (2), p.127-131

1992

Volltextzugriff (PDF)

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

Metabolism, clinical and experimental, 1989-09, Vol.38 (9), p.913-915

1989

Volltextzugriff (PDF)

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects

Thrombosis and haemostasis, 1987, Vol.57 (3), p.326-328

1987

Volltextzugriff (PDF)

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

Metabolism, clinical and experimental, 1986-03, Vol.35 (3), p.250-253

1986

Volltextzugriff (PDF)

Formation, Inhibition and Clearance of Plasmin in vivo

Haemostasis, 2000-07, Vol.30 (4), p.204-218

2000

Volltextzugriff (PDF)

A three-generation family presenting five cases of homozygosity for the 20210 G to A prothrombin variant

Thrombosis and haemostasis, 1998-11, Vol.80 (5), p.859-860

1998

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(89)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(89)
Female
(71)
Science & Technology
(65)
Life Sciences & Biomedicine
(64)
Male
(62)
Middle Aged
(44)
Biological And Medical Sciences
(35)
Medical Sciences
(31)
Hematology
(20)
Adolescent
(18)
Cardiovascular System & Cardiology
(15)
Endocrinology & Metabolism
(15)
Peripheral Vascular Disease
(15)
Risk Factors
(12)
Child
(11)
Obesity
(11)
Neurosciences & Neurology
(10)
Insulin Resistance
(9)
Plasminogen Activator Inhibitor 1 - Blood
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat

Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM study

Plasminogen activator inhibitor type‐1 is an independent marker of metabolic disorders in young adults born small for gestational age

A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss

Expression of adrenomedullin in adipose tissue of lean and obese women

The role of actigraphy in the study of sleep and circadian rhythms

Headache during pregnancy

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled

Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation

Endothelial cell dysfunction in HIV infection

Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

Formation, Inhibition and Clearance of Plasmin in vivo

A three-generation family presenting five cases of homozygosity for the 20210 G to A prothrombin variant

Aktive Filter

Suchergebnisse filtern